Veterinary Pain Management Market Analysis & Forecast: 2026-2033
The Veterinary Pain Management market was valued at USD 1,911.2 Mn in 2026 and is forecast to reach a value of USD 2,927.2 Mn by 2033 at a CAGR of 7.5% between 2026 and 2033.
Veterinary pain management is a crucial part of veterinary therapeutics. Pain in animals leads to delayed healing and exaggerated stress in already sick animals. Pain in animals could be due to cancer, arthritis, and surgeries, and may lead to reduced activity and aggression. The most important aim is pain management while efforts are made to spot and treat underlying disease and reinforce healing and recovery. Rising pet ownership, increasing animal welfare awareness, growing chronic diseases in pets, technological advances in analgesics, higher veterinary spending, and expanding veterinary infrastructure.
|
Current Event |
Description and its Impact |
|
Advances in Veterinary Pain Medications |
|
|
Growing Awareness of Animal Welfare and Pain Management |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In terms of product, the drugs segment is expected to lead the market with 80% share in 2026, owing to their well-established use, versatility across a range of species, and broad accessibility in both developed and emerging veterinary healthcare systems. The predominance of drugs in this market is fundamentally rooted in their proven efficacy in managing pain associated with a variety of conditions, including post-surgical pain, chronic musculoskeletal disorders like arthritis, and acute injuries in animals.
For instance, in December 2025, Felix Pharmaceuticals Pvt. Ltd., released, Firocoxib Tablets for Horses, for the control of pain as well as inflammation associated with osteoarthritis in horses. This dominance is further reinforced by the continual development of new veterinary analgesics, ensuring that drugs remain the preferred and most reliable solution for managing animal pain.
In terms of application, the osteoarthritis and joint pain segment is expected to hold 72.8% share of the market in 2026. Owing to the widespread prevalence of degenerative joint diseases in companion animals as well as livestock. Osteoarthritis is recognized as one of the most common chronic situation impacting aging pets, particularly dogs, cats, etc., causing persistent pain along with mobility issues.
For instance, according to December 2025 report of the University of Illinois Urbana-Champaign, Osteoarthritis (OA), also known as degenerative joint disease (DJD), is a common problem in small animal patients. An estimated 80% of dogs >8 years old and 60% of cats between 6 and 19 years old have OA. This high prevalence along with chronic nature of osteoarthritis make it the primary driver of treatment demand, reinforcing its dominant position in the market.
In terms of animal type, the companion segment is projected to account for 65% share of the market in 2026. Owing to several compelling factors related to the inclining dynamics of pet ownership, increased awareness of animal well-being, as well as advancements in veterinary healthcare. Over the past decades, there has been a major global increase in the number of companion animals, such as dogs, cats, and other small pets, driven largely by changing societal norms and urbanization that has enhanced the human-animal bond.
For instance, according to data from the American Pet Products Association, pet ownership in the U.S. hit an estimated 94 million households in 2025, up from 82 million in 2023. This trend highlights how urbanization as well as changing societal norms are fueling the growth of veterinary pain management products for companion animals.
In terms of end user, the hospitals and clinics segment is projected to capture 70% share in 2026, the Hospitals and Clinics segment holds the largest share of the market, underpinned by several critical factors tied to the infrastructure, expertise, and demand patterns inherent in veterinary healthcare settings. The dominance of Hospitals as well as Clinics can primarily be attributed to the centralized nature of veterinary treatment, especially for pain management, which often requires sophisticated diagnostic tools, specialized personnel, and comprehensive treatment protocols that these establishments are better equipped to provide.
To learn more about this report, Download Free Sample
North America is expected to dominate the veterinary pain management market with 50% share in 2026, owing to several critical socio-economic, regulatory, and technological factors that consolidate its leadership position. The existence of an advanced veterinary healthcare infrastructure, along with with the escalating prevalence of pet adoption and ownership, especially dogs and cats, drives the demand for sophisticated pain management solutions.
For instance, in 2025, the UC Davis William R. Pritchard Veterinary Medical Teaching Hospital opened the All-Species Imaging Center, now the most advanced veterinary imaging facility on the West Coast.
Asia Pacific is expected to exhibit the fastest growth, bolstered by rapid urbanization, increasing pet ownership, as well as surging awareness about animal welfare as well as pain management. Countries such as China, India, and Southeast Asian nations are witnessing an exponential increase in domestic pet populations, encouraging more frequent visits to veterinary care centers and the adoption of advanced medical pain management solutions.
A significant contributing factor to this growth is the rising penetration of veterinary pharmaceutical manufacturing within Asia-Pacific itself. Governments in China and India have progressively supported veterinary health infrastructure development through policies promoting animal health and preventive care, as reported by the Food and Agriculture Organization (FAO) of the United Nations.
The U.S. contributes the highest share in the Veterinary Pain Management Market in North America owing to various region-specific factors deeply rooted in its advanced veterinary healthcare infrastructure, regulatory environment, as well as robust animal welfare framework. The United States hosts a highly developed network of veterinary clinics, hospitals, and specialized pain management centers that adopt cutting-edge therapeutic technologies for companion and farm animals.
For instance, the U.S. government’s proactive initiatives through agencies such as the U.S. Department of Agriculture (USDA) as well as the Food and Drug Administration (FDA) have streamlined the approval of novel veterinary analgesics as well as devices, thereby facilitating faster clinical adoption.
Japan contributes the highest share in the veterinary pain management market owing to its advanced veterinary healthcare infrastructure, established regulatory framework, and heightened awareness among pet owners as well as livestock producers about animal welfare. The country has long maintained harsh standards for veterinary practices, supported by government initiatives promoting animal health and wellbeing.
For instance, the 11th Asian Pig Veterinary Society Congress (APVS 2025) took place in Fukuoka, Japan, from November 9 to 12, 2025, bringing together veterinarians, producers, researchers and industry professionals under the theme “Sustainable Future of Asian Pig Production.” Japan’s leadership is further strengthened by government initiatives and strict standards in veterinary care, which ensure high adoption of pain management treatments for both companion animals and livestock.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,911.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.5% | 2033 Value Projection: | USD 2,927.2 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Zoetis Inc., Vetoquinol SA, Norbrook, Dechra Pharmaceuticals PLC, Chanelle Veterinary Limited, Ceva Sante Animale, Assisi Animal Health, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The increasing trend of pet ownership globally is significantly influencing the expansion of the Veterinary Pain Management Market. Over the last few years, there has been a major inclination towards viewing pets as integral family members rather than just animals, leading to an upsurge in their healthcare as well as well-being demands. This evolution in pet care culture and demographics creates robust demand for l veterinary pain management products as well as services, positively influencing the market’s growth trajectory.
The escalating incidence of veterinary chronic as well as post-operative pain is significantly propelling the expansion of the veterinary pain management market globally. Historically, pain in animals was under-recognized and undertreated, largely due to limited understanding and diagnostic challenges. However, high awareness among veterinarians as well as pet owners about animal welfare has emphasized the importance of effective pain management strategies.
The development of novel analgesic drugs and biopharmaceuticals represents a major opportunity in the veterinary pain management market, primarily driven by the escalating recognition of animal welfare and advancements in pharmaceutical technologies. Traditional pain management in animals has long relied on a limited arsenal of non-steroidal anti-inflammatory drugs (NSAIDs), opioids, as well as corticosteroids. However, these treatments usually have constraints such as side effects, limited efficacy in chronic pain, as well as potential for misuse in some cases. Recent innovations in biopharmaceuticals, including monoclonal antibodies and gene therapies, are opening new avenues for more targeted, effective, and safer pain relief options in veterinary medicine.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
